glp-1 0 Why Foundayo, the new once-daily pill, is such a big deal GLP-1 Receptor Agonists Show Promise
Description
PlexusDx requires baseline depression screening and ongoing mood monitoring for all patients, especially those with mental health history
For type 2 diabetes management , NICE guidance (NG28) recommends GLP-1 agonists as second- or third-line therapy when metformin and other oral agents provide inadequate glycaemic control, or as an alternative to insulin in appropriate patients
& Arturi, F
As body weight decreases, total daily energy expenditure decreases, and the deficit that produced rapid early weight loss narrows
It's a complex interplay, and individual responses can vary greatly
